{"id":"https://openalex.org/W1983130067","doi":"https://doi.org/10.1111/j.1463-1326.2010.01214.x","title":"An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials","display_name":"An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials","alternate_titles":[],"publication_year":2010,"publication_date":"2010-04-20","ids":{"openalex":"https://openalex.org/W1983130067","doi":"https://doi.org/10.1111/j.1463-1326.2010.01214.x","mag":"1983130067","pmid":"https://pubmed.ncbi.nlm.nih.gov/20518805"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2010.01214.x","doi":"https://doi.org/10.1111/j.1463-1326.2010.01214.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2010.01214.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2010.01214.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1983130067"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2010.01214.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110222644","display_name":"Monica Ligueros\u2010Saylan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. Ligueros\u2010Saylan","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. monica.ligueros@novartis.com","Novartis Pharmaceuticals Corporation East Hanover, NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. monica.ligueros@novartis.com","institution_ids":[]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation East Hanover, NJ USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066047147","display_name":"James Edward Foley","orcid":"https://orcid.org/0000-0001-6857-1158","observed_orcids":["https://orcid.org/0000-0001-6857-1158"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. E. Foley","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007864342","display_name":"Anja Schweizer","orcid":"https://orcid.org/0000-0001-8787-3442","observed_orcids":["https://orcid.org/0000-0001-8787-3442"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Schweizer","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085624659","display_name":"A. Couturier","orcid":"https://orcid.org/0000-0003-0193-7324","observed_orcids":["https://orcid.org/0000-0003-0193-7324"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Couturier","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068333266","display_name":"Wolfgang Kothny","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Kothny","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110222644"],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":13.3582,"has_fulltext":true,"cited_by_count":149,"citation_normalized_percentile":{"value":0.99273687,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"12","issue":"6","first_page":"495","last_page":"509"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9480000138282776},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9629999995231628},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9459999799728394},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5479999780654907},{"id":"https://openalex.org/keywords/hepatic-enzyme-elevation","display_name":"hepatic enzyme elevation","score":0.7509999871253967},{"id":"https://openalex.org/keywords/pancreatitis","display_name":"pancreatitis","score":0.7599999904632568},{"id":"https://openalex.org/keywords/cutaneous-adverse-effects","display_name":"cutaneous adverse events","score":0.6200000047683716},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8180000185966492},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.328000009059906},{"id":"https://openalex.org/keywords/pooled-clinical-trial-data","display_name":"pooled clinical trial data","score":0.6100000143051147},{"id":"https://openalex.org/keywords/exposure-adjusted-incidence-rates","display_name":"exposure-adjusted incidence rates","score":0.656000018119812},{"id":"https://openalex.org/keywords/infections-and-infestations","display_name":"infections and infestations","score":0.7210000157356262},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.993394136428833},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7986853122711182},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6696636080741882},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5938114523887634},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5518860220909119},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5499248504638672},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4586934447288513},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.45767614245414734},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.4332626461982727},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.42196884751319885},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4161240756511688},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.32023850083351135},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077597","descriptor_name":"Vildagliptin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007107","descriptor_name":"Immune System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010179","descriptor_name":"Pancreas","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010179","descriptor_name":"Pancreas","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016001","descriptor_name":"Confidence Intervals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1463-1326.2010.01214.x","doi":"https://doi.org/10.1111/j.1463-1326.2010.01214.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2010.01214.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2010.01214.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:20518805","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20518805","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1463-1326.2010.01214.x","doi":"https://doi.org/10.1111/j.1463-1326.2010.01214.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2010.01214.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2010.01214.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1983130067.pdf","grobid_xml":"https://content.openalex.org/works/W1983130067.grobid-xml"},"referenced_works_count":60,"referenced_works":["https://openalex.org/W100598291","https://openalex.org/W167234302","https://openalex.org/W1913239326","https://openalex.org/W1916480346","https://openalex.org/W1951261947","https://openalex.org/W1969389642","https://openalex.org/W1970406523","https://openalex.org/W1972139681","https://openalex.org/W1973383046","https://openalex.org/W1975582407","https://openalex.org/W1977619586","https://openalex.org/W1979916078","https://openalex.org/W1979982110","https://openalex.org/W1982067008","https://openalex.org/W1984588810","https://openalex.org/W1996604226","https://openalex.org/W2000545769","https://openalex.org/W2011371613","https://openalex.org/W2011556186","https://openalex.org/W2020638064","https://openalex.org/W2024440860","https://openalex.org/W2024567427","https://openalex.org/W2024569808","https://openalex.org/W2027249582","https://openalex.org/W2031468509","https://openalex.org/W2032939032","https://openalex.org/W2033072177","https://openalex.org/W2040643300","https://openalex.org/W2047353065","https://openalex.org/W2049323977","https://openalex.org/W2051496470","https://openalex.org/W2052238486","https://openalex.org/W2055416829","https://openalex.org/W2055860056","https://openalex.org/W2057913111","https://openalex.org/W2063976195","https://openalex.org/W2065408836","https://openalex.org/W2073338611","https://openalex.org/W2074925580","https://openalex.org/W2079787842","https://openalex.org/W2088748627","https://openalex.org/W2089443047","https://openalex.org/W2092883481","https://openalex.org/W2099677425","https://openalex.org/W2101293928","https://openalex.org/W2103828712","https://openalex.org/W2109157463","https://openalex.org/W2114792859","https://openalex.org/W2117762041","https://openalex.org/W2118394718","https://openalex.org/W2119114384","https://openalex.org/W2124465362","https://openalex.org/W2126930838","https://openalex.org/W2134312738","https://openalex.org/W2137471483","https://openalex.org/W2140369318","https://openalex.org/W2165765596","https://openalex.org/W2167621077","https://openalex.org/W2170952317","https://openalex.org/W4238267759"],"related_works":["https://openalex.org/W2808825621","https://openalex.org/W2949918910","https://openalex.org/W2911959348","https://openalex.org/W4244816128","https://openalex.org/W2042457844","https://openalex.org/W2133274800","https://openalex.org/W4242932803","https://openalex.org/W2213547035","https://openalex.org/W1518038365","https://openalex.org/W2983778852"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"assess":[2],"the":[3,110,160,168,193,213],"safety":[4],"of":[5,18,28,85,133,207,246,254],"vildagliptin":[6,44,89,113,150,171,216,239],"versus":[7,69],"all":[8],"comparators":[9],"(ACs)":[10],"with":[11,31,57,71,104,142,149,215,243],"regard":[12],"to":[13,51,88,97],"organs,":[14],"systems":[15],"or":[16,49,145,156,249,260],"tissues":[17],"particular":[19],"interest":[20],"in":[21,55,159,192],"type":[22],"2":[23],"diabetes":[24],"(T2DM)":[25],"and":[26,60,64,93,105,123,138,165,181,188,195,212],"areas":[27],"potential":[29],"concern":[30],"dipeptidyl":[32],"peptidase-IV":[33],"(DPP-4)":[34],"inhibitors.":[35],"METHODS:":[36],"Data":[37],"were":[38,77,81,117,154,175,210],"pooled":[39],"from":[40,224],"38":[41],"studies":[42],"where":[43],"was":[45,199,220,240],"given":[46],"for":[47,112,139,170,189],">":[48,52,82,94,144],"=12":[50],"104":[53],"weeks":[54],"patients":[56],"T2DM.":[58],"Absolute":[59],"exposure-adjusted":[61,131],"incidence":[62],"rates":[63],"Peto":[65],"odds":[66],"ratios":[67],"(ORs)":[68],"ACs":[70,161,225],"corresponding":[72],"95%":[73],"confidence":[74],"intervals":[75],"(CI)":[76],"calculated.":[78],"RESULTS:":[79],"There":[80],"7000":[83],"subject-years":[84],"exposure":[86],"(SYE)":[87],"50":[90,114,151,172,217],"mg":[91,115,152,173,218],"bid":[92,116,153,174,219],"6500":[95],"SYE":[96],"ACs.":[98],"For":[99,163],"mild":[100],"hepatic":[101,136,164,247,250],"enzyme":[102,140,251],"elevations":[103,141,252],"without":[106],"elevated":[107,135],"bilirubin":[108,143],"levels,":[109],"ORs":[111,169],"1.24":[118],"(95%":[119,125,177,183,201,229],"CI:":[120,126,178,184,202,230],"[0.80,":[121,231],"1.93])":[122],"1.19":[124],"[0.29,":[127],"4.90]),":[128],"respectively.":[129],"The":[130,205,234],"incidences":[132,206],"markedly":[134],"enzymes":[137],"=":[146,157,227],"2x":[147],"ULN":[148],"<":[155],"those":[158],"group.":[162],"pancreatitis-related":[166],"AEs,":[167],"0.87":[176],"[0.64,":[179],"1.19])":[180],"0.70":[182],"[0.26,":[185],"1.88]),":[186],"respectively,":[187],"any":[190],"AE":[191],"infections":[194,259],"infestations":[196],"SOC,":[197],"this":[198],"1.04":[200],"[0.96,":[203],"1.13]).":[204],"skin-related":[208,261],"AEs":[209],"low":[211],"risk":[214,245],"not":[221,241],"significantly":[222],"different":[223],"[(OR":[226],"1.10":[228],"1.51])].":[232],"CONCLUSIONS:":[233],"present":[235],"meta-analyses":[236],"indicate":[237],"that":[238],"associated":[242],"increased":[244],"events":[248],"indicative":[253],"drug-induced":[255],"liver":[256],"injury,":[257],"pancreatitis,":[258],"toxicity.":[262]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1983130067","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":18},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":22}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
